Kawa K, Hara J
Osaka Medical Center and Research Institute for Maternal and Child Health.
Nihon Rinsho. 1992 Jun;50(6):1315-20.
More detailed identification and understanding of the heterogeneity of leukemias using a broad panel of markers seems to be essential for the successful design of more sophisticated and effective treatments. Based on the FAB system, immunological phenotypes using a panel of monoclonal antibodies, and rearrangements of immunoglobulin and T-cell receptor genes, acute leukemia can be divided into six subtypes such as B-lineage, T-lineage, AML, NK-lineage, AUL and mixed lineage leukemia. The definition of B-lineage and T-lineage cells, a new classification for mixed lineage leukemia, incidence of dual rearrangements and their clinical significance are discussed.
使用广泛的标志物组对白血病的异质性进行更详细的鉴定和理解,对于成功设计更复杂、有效的治疗方法似乎至关重要。基于FAB系统、使用一组单克隆抗体的免疫表型以及免疫球蛋白和T细胞受体基因的重排,急性白血病可分为六种亚型,如B系、T系、急性髓系白血病(AML)、NK系、急性未分化白血病(AUL)和混合谱系白血病。本文讨论了B系和T系细胞的定义、混合谱系白血病的新分类、双重重排的发生率及其临床意义。